Although studies have revealed an inhibitory role for PIAS3 against Stat5a/b-driven gene transcription and disease progression in breast cancer, the predominant Stat5a/b protein that binds to DNA has been shown to be N-terminally truncated in human prostate cancer cells and clinical prostate cancers [39]. Here, STAT5A is linked to breast carcinoma.